clinical research organization
Scope
Date
~
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Automobiles
Korea auto output to increase slightly in 2023: research
Domestic automobile output next year is forecast to increase 1.4% over this year to 3.7 million units.The Korea Automobile Manufacturers Association...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
GI Cell wins approval for human cell management from Korean regulator
GI Cell, a South Korean developer of immune cell therapy products, received a human cell and others management license from South Korean regulatory,...
Dec 27, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Banking & Finance
85% of S.Korea's Gen MZ have contactless savings accounts
A study finds 90% of South Korea's Generation MZ, a demographic comprising millennials and Generation Z members born between 1981 and 2010, use cont...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma confirms safety of flu vaccine in phase 1 trial
South Korea's leading pharmaceutical company GC Biopharma Corp. said on Thursday that it has confirmed the safety and immunogenicity of the patch-ty...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
ESG
SK Ecoplant earns AA grade for FTC's voluntary compliance program
South Korea's construction engineering company SK Ecoplant Co., Ltd. is accelerating its environmental, social, and governance (ESG) management effo...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Aerospace & Defense
LIG Nex1, KAIST, HHI sign MOU for unmanned marine system partnership
South Korea's defense contractor LIG Nex1 Co. took part in the "2022 Yi Sun-sin Defense Industry Exhibition" held at the Jinhae Naval Academy on Wed...
Dec 08, 2022 (Gmt+09:00)
-
Business & Politics
South Korea needs to attract more foreign professionals: FKI
In order to address the chronic shortage of industrial engineering manpower, a research report proposed that South Korea put more effort into attracti...
Dec 08, 2022 (Gmt+09:00)
-
Bio & Pharma
MDimune signs research agreement with Australian National University
MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...
Dec 07, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Healthcare
KT adds partner to expand Vietnam digital healthcare biz
KT Corp., a major South Korean telecom operator, has teamed up with another local company to expand its digital healthcare business in Vietnam furth...
Nov 07, 2022 (Gmt+09:00)
-
Perspectives
Korea should open retail electricity market for renewables
South Korea on Oct. 26 officially launched the carbon neutrality commission based on laws for green growth, which took effect last March, amid the g...
Nov 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio suffers as weak won lifts global clinical trial costs
South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...
Oct 14, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Hansol Group, KAIST to launch new tech, AI research center
South Korea’s Hansol Group and the Korea Advanced Institute of Science and Technology (KAIST) have agreed to establish a research center to de...
Oct 13, 2022 (Gmt+09:00)
-
Aerospace & Defense
ETRI bolsters semiconductor technologies for use in aerospace defense
Daejeon-based Electronics and Telecommunications Research Institute (ETRI) is poised to further the development of semiconductor technologies for us...
Sep 23, 2022 (Gmt+09:00)
-
Business & Politics
KAIST, NYU to operate joint campus in New York City from 2023
Korea Advanced Institute of Science and Technology (KAIST), South Korea's most prestigious national research university, and New York University wil...
Sep 22, 2022 (Gmt+09:00)
-
Artificial intelligence
NCSOFT publishes three AI academic papers at INTERSPEECH 2022
South Korea’s gaming giant NCSOFT Corp. will present three academic papers at INTERSPEECH 2022, the world’s largest and most comprehensi...
Sep 19, 2022 (Gmt+09:00)
-
Artificial intelligence
LG AI center joins forces with Parsons School for creative AI development
South Korea’s LG Corp. announced it signed an academic collaboration agreement with the New York City-based Parsons School of Design on Monday...
Sep 13, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Cash-rich Nongshim pursues first-ever sizeable acquisition
Nongshim Co., South Korea’s No. 1 instant noodle brand, is looking to buy a domestic food supplement maker for up to $50 million, which would ...
Sep 06, 2022 (Gmt+09:00)
-
Carbon neutrality
Lotte Group to donate $10.4 mn to KAIST to build R&D, design centers
Lotte Corp. announced on Monday that it will donate 14 billion won ($10.4 million) to the prestigious Korea Advanced Institute of Science and Techno...
Aug 29, 2022 (Gmt+09:00)
-
Electronics
Remote work, small offices revive S.Korea's printer market
South Korea’s printer market has been recovering from a long slump as the rise of remote work and small or home offices has revived demand for...
Aug 17, 2022 (Gmt+09:00)
-
Batteries
Boston emerges as Korean firms’ R&D hub for AI, batteries
Top South Korean conglomerates Samsung and Hyundai have selected Boston as the home of their first overseas research centers for batteries and artif...
Aug 16, 2022 (Gmt+09:00)
-
Automobiles
Hyundai to set up AI robotics R&D center near Boston
South Korea’s Hyundai Motor Group will set up an artificial intelligence research center in the Boston area to develop AI-driven robotics tech...
Aug 12, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand